University of South Alabama / Mitchell Cancer Institute Deptof Mitchell Cancer Inst(2) is a clinical research site located in Mobile, Alabama, United States 36688.
Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.
University of South Alabama / Mitchell Cancer Institute Deptof Mitchell Cancer Inst(2) has participated in 2 clinical trials.
Therapeutic areas: Breast Cancer, Advanced Neuroendocrine Tumors of Pancreatic Origin.
Sponsors: Novartis Pharmaceuticals.
Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
University of South Alabama / Mitchell Cancer Institute Deptof Mitchell Cancer Inst(2) has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of South Alabama / Mitchell Cancer Institute Deptof Mitchell Cancer Inst(2) has 2 clinical trials on record. Their work covers Breast Cancer, Advanced Neuroendocrine Tumors of Pancreatic Origin.
University of South Alabama / Mitchell Cancer Institute Deptof Mitchell Cancer Inst(2) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.